Home > Insider Trading > Filing (0001209191-18-023351)

Filing Details

Accession Number:: 0001209191-18-023351
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-04-03 20:12:11
Reporting Period:: 2018-03-31

Accepted Time:: 2018-04-03 20:12:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
897448	Amarin Corp Plc	AMRN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1408920	T Joseph Kennedy	C/O Amarin Pharma, Inc. 1430 Route 206 Bedminster NJ 07921	General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2018-03-31	47,187	$0.00	65,621	No	4	M	Direct
Ordinary Shares	Acquisiton	2018-03-31	6,250	$0.00	71,871	No	4	M	Direct
Ordinary Shares	Disposition	2018-03-31	26,495	$3.01	45,376	No	4	F	Direct
Ordinary Shares	Disposition	2018-04-02	7,900	$2.91	37,476	No	4	S	Direct
Ordinary Shares	Disposition	2018-04-03	19,042	$2.89	18,434	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Restricted Stock Units	Disposition	2018-03-31	47,187	$0.00	47,187	$0.00
Ordinary Shares	Restricted Stock Units	Disposition	2018-03-31	6,250	$0.00	6,250	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
235,937			No	4	M	Direct
31,250			No	4	M	Direct

Footnotes

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
As previously reported on July 8, 2015, the Reporting Person was granted 755,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in 16 equal quarterly installments. The eleventh vesting event occurred on March 31, 2018.
Not applicable.
Please see the section titled "Remarks" below for additional information.
As previously reported on October 6, 2015, the Reporting Person was granted 100,000 RSUs under the Plan. These RSUs vest in 16 equal quarterly installments. The eleventh vesting event occurred on March 31, 2018.
Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.
Sales made pursuant to a 10b5-1 trading plan dated December 9, 2016.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.87 to $3.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.83 to $2.935, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.